Analyst Expectations for Neurocrine Biosciences's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 22 analysts have published their opinion on Neurocrine Biosciences (NASDAQ:NBIX) stock. The average 12-month price target for the company is $128.55, with a high of $154.00 and a low of $96.00. This average price target has increased by 5.26% over the past month.
September 13, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a positive outlook on Neurocrine Biosciences, with an average 12-month price target of $128.55. This target has increased by 5.26% over the past month.
The average 12-month price target for Neurocrine Biosciences has increased over the past month, indicating a positive sentiment among analysts. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100